Discover
BDSX
Biodesix, Inc.
22.09
1 x 22.62
1 x 23.26
bid
ask
+
0.95
4.49%
12:00 PM
timesize
| Ytd | 224.85% | |
| 1y | 206.81% |
20.86
day range
22.20
5.46
52 week range
24.50
| Open | 21.14 | Prev Close | 21.14 | Low | 20.86 | High | 22.20 | Mkt Cap | 172.09M |
| Vol | 23.79K | Avg Vol | 77.19K | EPS | -4.06 | P/E | -5.21 | Forward P/E | -6.64 |
| Beta | 0.53 | Short Ratio | 0.83 | Inst. Own | 42.83% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-04 | 50-d Avg | 17.68 | 200-d Avg | 12.18 | 1yr Est | 3.10 |
| Income Statement | |||
| Total Revenue | 25.56M | ||
| Revenues (USD) | 25.56M | ||
| Cost of Revenue | 4.21M | ||
| Gross Profit | 21.35M | ||
| Operating Expenses | 27.55M | ||
| Research and Development Expense | 3.29M | ||
| Selling, General and Administrative Expense | 24.26M | ||
| Operating Income | -6.20M | ||
| Interest Expense | 1.98M | ||
| Net Income | -7.79M | ||
| Net Income Common Stock | -7.79M | ||
| Net Income Common Stock (USD) | -7.79M | ||
| Consolidated Income | -7.79M | ||
| Earnings per Basic Share | -0.81 | ||
| Earnings per Basic Share (USD) | -0.81 | ||
| Earnings per Diluted Share | -0.81 | ||
| Earning Before Interest & Taxes (EBIT) | -5.82M | ||
| Earning Before Interest & Taxes (USD) | -5.82M | ||
| Weighted Average Shares | 9.66M | ||
| Weighted Average Shares Diluted | 9.66M | ||
| Balance Sheet | |||
| Cash and Equivalents | 25.57M | ||
| Cash and Equivalents (USD) | 25.57M | ||
| Trade and Non-Trade Receivables | 9.50M | ||
| Current Assets | 40.91M | ||
| Property, Plant & Equipment Net | 27.38M | ||
| Total Assets | 94.64M | ||
| Debt Current | 1.45M | ||
| Total Debt | 71.61M | ||
| Current Liabilities | 14.49M | ||
| Debt Non-Current | 70.16M | ||
| Total Liabilities | 85.51M | ||
| Accumulated Retained Earnings (Deficit) | -505.55M | ||
| Shareholders Equity | 9.13M | ||
| Shareholders Equity (USD) | 9.13M | ||
| Assets Non-Current | 53.73M | ||
| Total Debt (USD) | 71.61M | ||
| Deferred Revenue | 223.00K | ||
| Goodwill and Intangible Assets | 18.48M | ||
| Liabilities Non-Current | 71.02M | ||
| Trade and Non-Trade Payables | 3.65M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1.42M | ||
| Net Cash Flow from Financing | 16.90M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 6.59M | ||
| Capital Expenditure | -144.00K | ||
| Issuance (Purchase) of Equity Shares | 17.57M | ||
| Issuance (Repayment) of Debt Securities | -33.00K | ||
| Net Cash Flow from Investing | -144.00K | ||
| Net Cash Flow from Operations | -10.17M | ||
| Share Based Compensation | 1.12M | ||